Submitted by Anonymous (not verified) on 26 January 2026 - 16:30
Human medicines European public assessment report (EPAR): Recarbrio, imipenem,cilastatin,relebactam, Date of authorisation: 13/02/2020, Revision: 8, Status: Authorised
Source: